PM
PharmaCyte Biotech, Inc.
PMCB · NASDAQ
$0.44 -8.03% (-$0.04)
1M -19.20%
Market Cap $4.75M
P/E Ratio -
Div. Yield -
ROE 50.84%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.14x
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 2,751.79%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 50.84%
ROA 41.55%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 45.28x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
37 /100
Moderate EPS volatility 250.18%
Profitable years 0
Beta 0.66x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre PMCB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joshua N. Silverman
Employees
2
Headquarters
Las Vegas